Ocular Gene Therapy

Opus Genetics has acquired the rights to develop two preclinical-stage AAV-based gene therapy product candidates for inherited retinal diseases from Iveric Bio, according to a company press release.

In this episode, I share my preview of the hot topics for the upcoming AAO 2022 annual meeting, including my thoughts on ocular gene therapy and new treatments in the works.

In clinical ophthalmology, we are used to fixing problems on a physical or mechanical level.

It has been decades since the concept of gene therapy emerged in the ophthalmology field.

Most ophthalmologists are familiar and comfortable with the application of devices and drugs in their daily practice.